Statistics
Publications
9
Citations
909
H-Index
9
Active since
2009
Jan Anderl is an author at Heidelberg Pharma (Germany) specializing in antibody conjugates, antibody-drug conjugates, and antibody conjugation.
Publications per year
2009–2023
9
9
Christiane A. Opitz, Ulrike Litzenburger, Christian Lutz et al. · Stem Cells · 2009 · 303 citations
TP53 loss creates therapeutic vulnerability in colorectal cancer
Yunhua Liu, Xinna Zhang, Cecil Han et al. · Nature · 2015 · 245 citations
Gerhard Moldenhauer, Alexei V. Salnikov, Sandra Lüttgau et al. · JNCI Journal of the National Cancer Institute · 2012 · 192 citations · Full text
Medicine, Oncology, Pharmacology +12
1–5 of 9